Patents by Inventor Guangyun Lin

Guangyun Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Device for camouflaging an object from infrared and low light cameras
    Patent number: 9777998
    Abstract: A device is provided for camouflaging an object from an infrared detection apparatus. The device includes a cloak positionable between the object and the infrared detection apparatus. The cloak includes a layer of infrared absorptive material including a plurality of silicon nanowires. A flexible substrate has a first surface operatively connected to an inner surface of the layer. The substrate includes a heat dissipation arrangement for dissipating heat generated by the cloak during operation. An array of infrared emitters is operatively connected to a second surface of the substrate. The array of infrared emitters selectively radiates an infrared pattern to disguise the object to the infrared detection apparatus.
    Type: Grant
    Filed: September 21, 2016
    Date of Patent: October 3, 2017
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Hongrui Jiang, Seyyed Mohammad Javad Moghimi, Guangyun Lin
  • Purification, characterization, and use of Clostridium botulinum neurotoxin BoNT/A3
    Patent number: 9498521
    Abstract: Preparations of Clostridium botulinum neurotoxin BoNT/A3 and methods for using such preparations for treating a patient having a symptom in need of botulinum toxin therapy are provided herein.
    Type: Grant
    Filed: September 26, 2012
    Date of Patent: November 22, 2016
    Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Eric Johnson, William Tepp, Guangyun Lin
  • Purification, Characterization, and Use of Clostridium Botulinum Neurotoxin BoNT/A3
    Publication number: 20150250861
    Abstract: Preparations of Clostridium botulinum neurotoxin BoNT/A3 and methods for using such preparations for treating a patient having a symptom in need of botulinum toxin therapy are provided herein.
    Type: Application
    Filed: September 26, 2012
    Publication date: September 10, 2015
    Inventors: Eric Johnson, William Tepp, Guangyun Lin
  • Subtype of neurotoxin type A and uses thereof
    Patent number: 8440204
    Abstract: A novel subtype of type A botulinum neurotoxin (BoNT/A) is disclosed in the application. Methods to purify the neurotoxin as well as uses thereof are also disclosed.
    Type: Grant
    Filed: April 29, 2010
    Date of Patent: May 14, 2013
    Assignees: Wisconsin Alumni Research Foundation, The Scripps Research Institute
    Inventors: Eric A. Johnson, Mark Joseph Jacobson, Guangyun Lin, Raymond C. Stevens, Jerome Dupuy, P{dot over (a)}l Erik Gustav Stenmark, William H. Tepp
  • Novel Subtype of Closteridium Botulinum Neurotoxin Type A and Uses Thereof
    Publication number: 20110171226
    Abstract: A novel subtype of type A botulinum neurotoxin (BoNT/A) is disclosed in the application. Methods to purify the neurotoxin as well as uses thereof are also disclosed.
    Type: Application
    Filed: April 29, 2010
    Publication date: July 14, 2011
    Applicants: WISCONSIN ALUMNI RESEARCH FOUNDATION, THE SCRIPPS RESEARCH INSTITUTE
    Inventors: ERIC A. JOHNSON, MARK JOSEPH JACOBSON, GUANGYUN LIN, RAYMOND C. STEVENS, JEROME DUPUY, Pal Erik Gustav STENMARK, WILLIAM H. TEPP
  • Stable cell lines resistant to apoptosis and nutrient stress and methods of making same
    Patent number: 7405038
    Abstract: Cell lines that are commonly used for protein expression are engineered to include genes that encode suppressors of apoptosis (SA). Insect cell lines expressing these SA genes are resistant to apoptosis or programmed cell death, and express certain recombinant proteins at increased levels. These cell lines also have increased resistance to many types of stress. Because some of the SA proteins inhibit apoptosis in a wide spectrum of organisms, these genes may be inserted into other plant or animal cell lines for a variety of purposes involving resistance to apoptosis or resistance to stress.
    Type: Grant
    Filed: March 3, 2000
    Date of Patent: July 29, 2008
    Assignee: Boyce Thompson Institute for Plant Research, Inc.
    Inventors: Gary Blissard, Robert R. Granados, Guangyun Lin